Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
-
Italy's Meloni denies discussing SpaceX deal with Musk
-
Wolves sign Ivory Coast defender Agbadou from Reims
-
Lebanon army chief short of required majority in first round of president vote
-
Beijing says EU imposed unfair trade barriers on Chinese firms
-
Global stock markets mixed tracking US rates outlook
-
West Ham appointment feels like 'Christmas' says new boss Potter
-
Thousands welcome Mozambique opposition leader as he returns from exile
-
US emissions stagnate in 2024, challenging climate goals: study
-
China's electric and hybrid vehicle sales jump 40.7% in 2024
-
UK FM Lammy refuses to condemn Trump comments on Greenland
-
Lebanon meets to finally elect president after two-year vacancy
-
Potter says it feels like 'Christmas' as he becomes West Ham boss
-
Potter named West Ham boss after Lopetegui sacking
-
Blinken seeks to avert Syria turmoil with Europeans on final trip
-
Mozambique opposition leader returns home, ready for government talks
-
Waymo exec hopeful Trump will boost autonomous driving
-
YouTube patriots? The men backing S. Korea's impeached president
-
Top seeds Pegula, Paul surge into Adelaide semis
-
Asian markets hit by worries over US inflation, rates outlook
-
Celebrities flee Los Angeles fires, lose houses as Hollywood events scrapped
-
Raspy-voiced hit machine Rod Stewart turns 80
-
Tensions high in Mozambique as opposition leader due home from exile
-
Trade war worries loom over Las Vegas tech show
-
America mourns former president Jimmy Carter at state funeral
-
Djokovic handed tough Australian Open draw, Sinner faces Jarry test
-
Bok prop Nche wary of Dupont threat in Champions Cup
-
Conceicao brings good vibes back to AC Milan after Super Cup triumph
-
'We have lost everything': Despair in the Los Angeles fires
-
Australia frets over Meta halt to US fact-checking
-
Japan startup hopeful ahead of second moon launch
-
Ukraine allies to hold last defence meet before Trump takes office
-
NBA-best Cavs win 11th in a row to end 15-game Thunder streak
-
What you need to know about HMPV
-
Venezuela braces for crunch anti-Maduro protests
-
Bangladesh garment industry rebounds, but workers say little change
-
Asian markets drop as trades fret over US inflation, rates outlook
-
Mozambique opposition leader due home amid tension over disputed vote
-
Doping and a match made in heaven: Australian Open storylines
-
Australia recall McSweeney for Sri Lanka Tests, Connolly set for debut
-
Myanmar military adopts anti-junta fighters' drone tactics
-
Lebanon set to finally elect president after two-year vacancy
-
New twist in US-Cuba trademark fight over Havana Club rum
-
CES tech looks to help world's aging population
-
Venezuela repression increases ahead of crunch anti-Maduro protests
-
Rubber tappers forge sustainable future in Amazon
-
'No more fires,' demand fed-up Amazon residents
-
Assault on Chad presidential complex leaves 19 dead
-
Crowds throng as Jesus statue parades through Philippine capital
-
Linde Announces Fourth Quarter 2024 Earnings and Conference Call Schedule
-
Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement Therapy Decisions
NYSE - LSE
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. This significant milestone underscores the strategic value of the agreement and demonstrates the potential of Bionoid's growth strategy.
The LOI with Your Supplement Supply Store Ltd. represents a pivotal step in Bionoid's expansion into the health and wellness e-commerce sector. Under the terms of the agreement, Bionoid retains all revenue generated during the transition period prior to the finalization of the Asset Purchase Agreement (APA). This structure has enabled Bionoid to capture immediate value while ensuring a seamless integration process.
"The revenue generated from this agreement is a testament to the strength of our strategic partnerships and our ability to drive results even before completing the acquisition process," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "This success reinforces our commitment to building a robust e-commerce presence in the health and wellness sector and highlights the potential for future growth as we continue to execute our long-term vision."
Bionoid's strategy focuses on acquiring high-value e-commerce platforms and leveraging its proprietary AI Maverick technology to optimize customer engagement and operational efficiency. The success of this initial revenue generation further positions the company as a leader in the health and wellness market.
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a forward-thinking health and wellness company dedicated to expanding revenue streams and enhancing brand presence through strategic acquisitions and advanced AI technology. Its proprietary AI Maverick platform supports the company's mission to deliver innovative, AI-driven solutions that foster customer loyalty, operational excellence, and sustainable growth.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
X (formally Twitter)
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma, Inc.
O.Karlsson--AMWN
